BridgeMD
Prevention study for Chemotherapy-induced Peripheral Neuropathy
Official title A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
ClinicalTrials.gov ID: NCT05606068
What this study is testing
- What it's testing
- The study conducted on cancer patients is designed to test safety and efficacy of limb hypothermia in cancer patients using the new Paxman Limb Cryocompression System (PLCS). Ultimately this will lead to the development of a therapy regime that will help to prevent chemotherapy-induced neuropathy in cancer patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80
You may be able to join if
- Age 21- 80 years.
- Signed informed consent from patient or legal representative
- Scheduled to receive weekly paclitaxel chemotherapy
- Patients may receive other chemotherapy drugs alongside taxane e.g. Platinum/Herceptin.
You likely can't join if
- Open skin wound or ulcers of the limbs
- History of Raynaud's phenomenon, peripheral vascular disease, or poorly controlled diabetes
- Pregnant woman
- A score of more than 5 in Total Neuropathy Score (TNS) at baseline for cancer patients
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.